MX394076B - Peptido que comprende un fragmento antigenico derivado de la capside del virus de la hepatitis c y kit para detectar una infeccion por vhc - Google Patents

Peptido que comprende un fragmento antigenico derivado de la capside del virus de la hepatitis c y kit para detectar una infeccion por vhc

Info

Publication number
MX394076B
MX394076B MX2018004313A MX2018004313A MX394076B MX 394076 B MX394076 B MX 394076B MX 2018004313 A MX2018004313 A MX 2018004313A MX 2018004313 A MX2018004313 A MX 2018004313A MX 394076 B MX394076 B MX 394076B
Authority
MX
Mexico
Prior art keywords
capsid
hepatitis
virus
infection
peptide
Prior art date
Application number
MX2018004313A
Other languages
English (en)
Inventor
François Rieunier
Stéphane Gadelle
Original Assignee
Bio Rad Europe Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Europe Gmbh filed Critical Bio Rad Europe Gmbh
Publication of MX394076B publication Critical patent/MX394076B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un péptido que comprende o consiste en un fragmento antigénico derivado de la cápside de. virus de la Hepatitis C, así como con una mutación puntual; también se refiere a conjugados peptídicos que comprenden dicho péptido, y a kits para detectar una infección por virus de la Hepatitis C.
MX2018004313A 2011-12-20 2012-12-19 Peptido que comprende un fragmento antigenico derivado de la capside del virus de la hepatitis c y kit para detectar una infeccion por vhc MX394076B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1161981A FR2984328B1 (fr) 2011-12-20 2011-12-20 Procede de detection d'une infection par le virus de l'hepatite c
PCT/FR2012/053001 WO2013093345A1 (fr) 2011-12-20 2012-12-19 Procede de detection d'une infection par le virus de l'hepatite c

Publications (1)

Publication Number Publication Date
MX394076B true MX394076B (es) 2025-03-24

Family

ID=47599082

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018004313A MX394076B (es) 2011-12-20 2012-12-19 Peptido que comprende un fragmento antigenico derivado de la capside del virus de la hepatitis c y kit para detectar una infeccion por vhc
MX2014007437A MX365962B (es) 2011-12-20 2012-12-19 Procedimiento de detección de una infección por el virus de la hepatitis c.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2014007437A MX365962B (es) 2011-12-20 2012-12-19 Procedimiento de detección de una infección por el virus de la hepatitis c.

Country Status (12)

Country Link
US (2) US9719994B2 (es)
EP (1) EP2794638B1 (es)
JP (1) JP6312600B2 (es)
CN (1) CN104302660B (es)
AR (1) AR089335A1 (es)
AU (1) AU2012356512B2 (es)
BR (1) BR112014015201A2 (es)
CA (1) CA2859736C (es)
FR (1) FR2984328B1 (es)
MX (2) MX394076B (es)
TW (1) TW201337268A (es)
WO (1) WO2013093345A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
CN113419061B (zh) * 2020-06-19 2022-02-01 南京金斯瑞生物科技有限公司 检测SARS-CoV-2病毒中和抗体的磁微粒化学发光试剂盒及其应用
EP4514984A4 (en) * 2022-04-25 2026-04-22 Beijing Hanmoluojie Tech Co Ltd 3D MOLECULAR SURFACE FEATURES MAPPING OF AAV CAPSIDS

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693489A (en) 1984-03-30 1997-12-02 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5683864A (en) 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6027729A (en) 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
HU217025B (hu) 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
ES2188583T3 (es) 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
RU2212899C2 (ru) 1991-09-13 2003-09-27 Чирон Корпорейшн Hcv иммунореактивные полипептидные композиции
SG77551A1 (en) 1992-03-06 2005-04-28 Innogenetics Nv Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing
FR2690921B1 (fr) 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
DK0698216T4 (da) 1993-05-10 2009-06-15 Novartis Vaccines & Diagnostic Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
WO1994026306A1 (en) 1993-05-12 1994-11-24 Chiron Corporation Conserved motif of hepatitis c virus e2/ns1 region
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE69534296T2 (de) 1994-07-29 2006-04-27 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Sezernierter E1/E2-Komplex des Hepatitis C-Virus, des aus C-terminal verkürzten Polypeptiden E1 und E2 erhalten ist
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
DK0752102T3 (da) 1995-01-23 2001-01-08 Pasteur Sanofi Diagnostics Immunoenzymatisk konjugat, fremgangsmåde til fremstilling af konjugatet og anvendelse af dette.
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
JP3715027B2 (ja) 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
EP0870830A3 (en) 1997-02-10 2004-02-25 Advanced Life Science Institute, Inc. Chimera hepatitis C virus antigen
ES2286852T3 (es) 1997-08-04 2007-12-01 Advanced Life Science Institute, Inc. Metodos para detectar o analizar virus.
CA2491918C (en) 1997-08-04 2007-10-16 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
CA2607990C (en) 1997-08-04 2009-09-22 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
DK1071955T4 (da) 1998-04-17 2009-06-15 Innogenetics Nv Forbedrede immundiagnostiske assays, som anvender reduktionsmidler
CA2305192C (en) 1998-07-30 2009-10-13 Advanced Life Science Institute, Inc. Method for assaying hepatitis c virus
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
ES2279766T3 (es) 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
SI1354204T2 (sl) 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza
SG118120A1 (en) 2001-03-28 2006-01-27 Ortho Clinical Diagnostics Inc A hepatitis C antigen - antibody combination assayfor the early detection of HCV infection
JP4353793B2 (ja) 2001-06-26 2009-10-28 アボット・ラボラトリーズ Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7049060B2 (en) 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US20030108563A1 (en) * 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies
US7332269B2 (en) 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
ES2312806T3 (es) 2002-09-09 2009-03-01 Novartis Vaccines And Diagnostics, Inc. Ensayo de vhc.
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
WO2010112733A1 (fr) * 2009-03-30 2010-10-07 bioMérieux Support solide de détection du vhc
US20100297607A1 (en) 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
CN102081018A (zh) 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法

Also Published As

Publication number Publication date
US20170328905A1 (en) 2017-11-16
AU2012356512A1 (en) 2014-07-24
AU2012356512B2 (en) 2017-07-20
JP6312600B2 (ja) 2018-04-18
US20140335508A1 (en) 2014-11-13
US9719994B2 (en) 2017-08-01
CN104302660A (zh) 2015-01-21
CN104302660B (zh) 2018-04-20
FR2984328A1 (fr) 2013-06-21
BR112014015201A2 (pt) 2019-09-24
CA2859736A1 (fr) 2013-06-27
CA2859736C (fr) 2021-03-30
AR089335A1 (es) 2014-08-13
MX365962B (es) 2018-05-04
EP2794638B1 (fr) 2020-05-27
MX2014007437A (es) 2015-03-03
WO2013093345A1 (fr) 2013-06-27
TW201337268A (zh) 2013-09-16
JP2015502552A (ja) 2015-01-22
US10345305B2 (en) 2019-07-09
FR2984328B1 (fr) 2016-12-30
EP2794638A1 (fr) 2014-10-29

Similar Documents

Publication Publication Date Title
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
WO2014143343A8 (en) Hcv core lipid binding domain monoclonal antibodies
CL2013003248A1 (es) Composición inmunogenica que comprende una glucoproteina g de los virus hendra y nipah y un complejo inmunoestimulante; método para producir una respuesta de anticuerpo neutralizante contra un virus hendra y/o nipah en un sujeto.
EP3587439A3 (en) Improved quantification of vaccine compositions
EA201492110A1 (ru) Вакцины против впг-2
SG11201810029PA (en) Immunochromatography Analysis Device for Detecting Zika Virus
TW201233686A (en) Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same
WO2009035412A8 (en) Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
MX2014011504A (es) Metodos para la deteccion de anticuerpos neutralizantes anticitomegalovirus.
EA201071086A1 (ru) Усовершенствованный способ получения вакцинных антигенов вируса гриппа
WO2015196192A3 (en) Methods and compositions relating to dengue virus
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
MX2015012824A (es) Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
EA201991843A1 (ru) Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов
EA202191931A1 (ru) Способ характеризации видимых и/или невидимых частиц в биологических препаратах
MX394076B (es) Peptido que comprende un fragmento antigenico derivado de la capside del virus de la hepatitis c y kit para detectar una infeccion por vhc
EP1806363A4 (en) PROCEDURE FOR DETECTION OF HEPATITIS B VIRUS S ANTIGEN
ME02909B (me) Poboljšana cjepivna dijagnostika
WO2011118982A3 (ko) 융합 폴리펩타이드 hpv 항원을 이용한 ｈｐｖ 항체 스크리닝 방법
WO2016069762A3 (en) Subject anti-hcv antibody detection assays employing ns3 capture peptides
WO2007108568A8 (en) Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
PH12012000361B1 (en) Method for detecting flaviviridae virus infection
WO2012114312A3 (en) Exogenous internal positive control
MX2016009952A (es) Proteinas y antigenos del virus de diarrea epidemica porcino (pedv).
TW200722527A (en) Methods of detecting hepatitis C virus